DOCGO INC (DCGO) Stock Fundamental Analysis
NASDAQ:DCGO - Nasdaq - US2560861096 - Common Stock - Currency: USD
DCGO gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 103 industry peers in the Health Care Providers & Services industry. No worries on liquidiy or solvency for DCGO as it has an excellent financial health rating, but there are worries on the profitability. DCGO has a valuation in line with the averages, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
DCGO had positive earnings in the past year.
In the past year DCGO had a positive cash flow from operations.
DCGO had positive earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: DCGO reported negative operating cash flow in multiple years.
1.2 Ratios
Looking at the Return On Assets, with a value of -0.15%, DCGO is in line with its industry, outperforming 47.57% of the companies in the same industry.
DCGO has a Return On Equity (-0.21%) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.15% | ||
| ROE | -0.21% | ||
| ROIC | N/A |
ROA(3y)4.86%
ROA(5y)1.57%
ROE(3y)7.06%
ROE(5y)1.16%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
DCGO's Profit Margin has declined in the last couple of years.
In the last couple of years the Operating Margin of DCGO has declined.
With a decent Gross Margin value of 34.03%, DCGO is doing good in the industry, outperforming 63.11% of the companies in the same industry.
DCGO's Gross Margin has been stable in the last couple of years.
DCGO does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 34.03% |
OM growth 3Y-8.41%
OM growth 5YN/A
PM growth 3Y-24.17%
PM growth 5YN/A
GM growth 3Y0.21%
GM growth 5YN/A
2. Health
2.1 Basic Checks
DCGO does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, DCGO has less shares outstanding
The debt/assets ratio for DCGO is higher compared to a year ago.
2.2 Solvency
An Altman-Z score of 2.33 indicates that DCGO is not a great score, but indicates only limited risk for bankruptcy at the moment.
DCGO has a Altman-Z score (2.33) which is comparable to the rest of the industry.
DCGO has a debt to FCF ratio of 0.55. This is a very positive value and a sign of high solvency as it would only need 0.55 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.55, DCGO belongs to the top of the industry, outperforming 90.29% of the companies in the same industry.
A Debt/Equity ratio of 0.13 indicates that DCGO is not too dependend on debt financing.
DCGO has a Debt to Equity ratio of 0.13. This is in the better half of the industry: DCGO outperforms 70.87% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.13 | ||
| Debt/FCF | 0.55 | ||
| Altman-Z | 2.33 |
ROIC/WACCN/A
WACC8.1%
2.3 Liquidity
A Current Ratio of 2.44 indicates that DCGO has no problem at all paying its short term obligations.
With an excellent Current ratio value of 2.44, DCGO belongs to the best of the industry, outperforming 84.47% of the companies in the same industry.
DCGO has a Quick Ratio of 2.44. This indicates that DCGO is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 2.44, DCGO belongs to the best of the industry, outperforming 85.44% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.44 | ||
| Quick Ratio | 2.44 |
3. Growth
3.1 Past
The earnings per share for DCGO have decreased strongly by -65.00% in the last year.
Measured over the past years, DCGO shows a decrease in Earnings Per Share. The EPS has been decreasing by -9.93% on average per year.
Looking at the last year, DCGO shows a very negative growth in Revenue. The Revenue has decreased by -26.01% in the last year.
The Revenue has been growing by 24.60% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-65%
EPS 3Y-9.93%
EPS 5YN/A
EPS Q2Q%-190%
Revenue 1Y (TTM)-26.01%
Revenue growth 3Y24.6%
Revenue growth 5YN/A
Sales Q2Q%-50.01%
3.2 Future
Based on estimates for the next years, DCGO will show a very negative growth in Earnings Per Share. The EPS will decrease by -37.99% on average per year.
DCGO is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -15.82% yearly.
EPS Next Y-233.38%
EPS Next 2Y-55.3%
EPS Next 3Y-37.99%
EPS Next 5YN/A
Revenue Next Year-49.7%
Revenue Next 2Y-27.64%
Revenue Next 3Y-15.82%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 21.29, which indicates a rather expensive current valuation of DCGO.
Based on the Price/Earnings ratio, DCGO is valued a bit cheaper than 66.99% of the companies in the same industry.
DCGO's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.30.
The Forward Price/Earnings Ratio is negative for DCGO. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.29 | ||
| Fwd PE | N/A |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, DCGO is valued cheaply inside the industry as 90.29% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of DCGO indicates a rather cheap valuation: DCGO is cheaper than 100.00% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 1.75 | ||
| EV/EBITDA | 5.96 |
4.3 Compensation for Growth
A cheap valuation may be justified as DCGO's earnings are expected to decrease with -37.99% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-55.3%
EPS Next 3Y-37.99%
5. Dividend
5.1 Amount
DCGO does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
1.49
-0.01 (-0.67%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners59.61%
Inst Owner Change0%
Ins Owners6.96%
Ins Owner Change4.5%
Market Cap147.66M
Analysts78.46
Price Target3.11 (108.72%)
Short Float %6.55%
Short Ratio5.34
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-165.5%
Min EPS beat(2)-311.74%
Max EPS beat(2)-19.26%
EPS beat(4)1
Avg EPS beat(4)-84.64%
Min EPS beat(4)-311.74%
Max EPS beat(4)0.93%
EPS beat(8)2
Avg EPS beat(8)-66.93%
EPS beat(12)4
Avg EPS beat(12)-46.24%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-9.08%
Min Revenue beat(2)-9.68%
Max Revenue beat(2)-8.47%
Revenue beat(4)0
Avg Revenue beat(4)-5.03%
Min Revenue beat(4)-9.68%
Max Revenue beat(4)-0.57%
Revenue beat(8)4
Avg Revenue beat(8)0.9%
Revenue beat(12)7
Avg Revenue beat(12)1.96%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-39.6%
EPS NQ rev (1m)-6.46%
EPS NQ rev (3m)-407.75%
EPS NY rev (1m)-451.32%
EPS NY rev (3m)-11788.1%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-22.53%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-23.94%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.29 | ||
| Fwd PE | N/A | ||
| P/S | 0.28 | ||
| P/FCF | 1.75 | ||
| P/OCF | 1.63 | ||
| P/B | 0.48 | ||
| P/tB | 0.64 | ||
| EV/EBITDA | 5.96 |
EPS(TTM)0.07
EY4.7%
EPS(NY)-0.11
Fwd EYN/A
FCF(TTM)0.85
FCFY57.12%
OCF(TTM)0.91
OCFY61.38%
SpS5.25
BVpS3.12
TBVpS2.35
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.15% | ||
| ROE | -0.21% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 34.03% | ||
| FCFM | 16.2% |
ROA(3y)4.86%
ROA(5y)1.57%
ROE(3y)7.06%
ROE(5y)1.16%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)8.11%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-8.41%
OM growth 5YN/A
PM growth 3Y-24.17%
PM growth 5YN/A
GM growth 3Y0.21%
GM growth 5YN/A
F-Score5
Asset Turnover1.21
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.13 | ||
| Debt/FCF | 0.55 | ||
| Debt/EBITDA | 2.9 | ||
| Cap/Depr | 40.69% | ||
| Cap/Sales | 1.21% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 634.7% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.44 | ||
| Quick Ratio | 2.44 | ||
| Altman-Z | 2.33 |
F-Score5
WACC8.1%
ROIC/WACCN/A
Cap/Depr(3y)50.15%
Cap/Depr(5y)71.98%
Cap/Sales(3y)1.27%
Cap/Sales(5y)2.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-65%
EPS 3Y-9.93%
EPS 5YN/A
EPS Q2Q%-190%
EPS Next Y-233.38%
EPS Next 2Y-55.3%
EPS Next 3Y-37.99%
EPS Next 5YN/A
Revenue 1Y (TTM)-26.01%
Revenue growth 3Y24.6%
Revenue growth 5YN/A
Sales Q2Q%-50.01%
Revenue Next Year-49.7%
Revenue Next 2Y-27.64%
Revenue Next 3Y-15.82%
Revenue Next 5YN/A
EBIT growth 1Y-102.46%
EBIT growth 3Y14.13%
EBIT growth 5YN/A
EBIT Next Year-89.9%
EBIT Next 3Y-27.25%
EBIT Next 5YN/A
FCF growth 1Y516.49%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y824.48%
OCF growth 3YN/A
OCF growth 5YN/A